Prognosis of paradoxical low-flow low-gradient aortic stenosis after transcatheter aortic valve replacement. Issue 6 (June 2021)

• Record Type: Journal Article
• Authors: Saito, Yukihiro; Lewis, Erik E.; Raval, Amish; Gimelli, Giorgio; Jacobson, Kurt; Osaki, Satoru
• Is Part Of: Journal of cardiovascular medicine. Volume 22:Issue 6(2021)
• Publication Date: 2021-06
• Subjects: paradoxical low-flow low-gradient severe -- severe aortic stenosis -- transcatheter aortic valve replacement; Cardiology -- Periodicals; Cardiovascular system -- Diseases -- Periodicals; Cardiology -- Periodicals; Cardiovascular Diseases -- Periodicals; 616.1005
• DOI: 10.2459/JCM.0000000000001139
• Languages: English
• ISSNs: 1558-2027

Abstract

Abstract : Aims: In paradoxical low-flow low-gradient severe aortic stenosis (PLFLG AS) patients, stroke volume index (SVI) is reduced despite preserved left ventricular ejection fraction (LVEF). Although reduced SVI is already known as a poor prognostic predictor, the outcomes of PLFLG AS patients after transcatheter aortic valve replacement (TAVR) have not been clearly defined. We retrospectively investigated the post-TAVR outcomes of PLFLG AS patients in comparison with normal-flow high-gradient aortic stenosis (NFHG AS) patients. Methods: The current observational study included 245 patients with NFHG AS (mean transaortic pressure gradient ≥40 mmHg and LVEF ≥ 50%) and 48 patients with PLFLG AS (mean transaortic pressure gradient <40 mmHg, LVEF ≥ 50% and SVI < 35 ml/m 2 ). The endpoints were all-cause mortality, hospitalization for valve-related symptoms or worsening congestive heart failure and New York Heart Association functional class III or IV. Results: PLFLG AS patients had a significantly higher proportion with a history of atrial fibrillation/flutter as compared with NFHG AS patients. All-cause mortality of PLFLG AS patients was worse than that of NFHG AS patients ( P = 0.047). Hospitalization for valve-related symptoms or worsening congestive heart failure was more frequent in PLFLG AS patients than in NFHG AS patients ( P = 0.041). New York Heart Association functional class III–IV after TAVR was more frequently observed in PLFLG AS patients ( P = 0.019). Conclusion: The outcomes of PLFLG AS patients were worse than those of NFHG AS patients in this study. Preexisting atrial fibrillation/flutter was frequent in PLFLG AS patients, and may affect their post-TAVR outcomes. Therefore, closer post-TAVR follow-up should be considered for these patients.